You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

  • Technology appraisal guidance
  • Reference number: TA210
  • Published:  15 December 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Appraisal Committee members, and NICE project team
  • 7 Sources of evidence considered by the Committee
  • Update information

Update information

February 2014: Implementation section updated to clarify that clopidogrel and modified-release dipyridamole is recommended as an option for preventing occlusive vascular events.

ISBN: 978-1-4731-6655-4


Previous page 7 Sources of evidence considered by the Committee
Back to top